A cholinesterase-inhibitor prodrug for symptoms of eligible Alzheimer disease; it does not cure the disease.
Profile scope: Benzgalantamine. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Appetite loss, digestive symptoms, dizziness, headache, weight loss, or mood symptoms may occur.
Serious risks and warning signs
Slow pulse, fainting, gastrointestinal bleeding, serious skin reactions, seizures, urinary problems, or worsening breathing requires assessment. Black stools, bloody vomit, chest symptoms, or blistering needs urgent advice. Avoid unplanned duplication with related treatments.
A question for your healthcare team
How will pulse, weight, digestive tolerance, and interactions with other dementia medicines be reviewed?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.